LDLR and prostate carcinoma: In addition, LDL-mediated effects on proliferation of prostate cancer cells are caused by PTEN loss and activation of Akt and ERK signaling pathways, and further activates SREBP, upregulating LDLR leading to cholesterol accumulation and cholesterol ester production (130).